| Name | Gardens On Quail |
|---|---|
| Location | 6447 Quail St, Arvada, Colorado |
| Certified By | Medicare |
| No. of Certified Beds | 60 |
| Occupancy Rate | 56.17% |
| Medicare ID (CCN) | 065406 |
| Legal Business Name | G O Q |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1366896730 |
| Organization Name | GOQ |
| Doing Business As | GARDENS ON QUAIL |
| Address | 6447 Quail St, Arvada, CO 80004 |
| Phone Number | 303-456-1500 |
News Archive
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
A study published today by the JAMA Network Open shows that in the period from October 2015 to September 2016 before the Affordable Care Act, a substantial portion of Medicare patients referred to home health care after hospitalization did not receive that care.
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
› Verified 9 days ago
| NPI Number | 1578813127 |
| Organization Name | THE GARDENS ON QUAIL STREET, LLC |
| Address | 6447 Quail St, Arvada, CO 80004 |
| Phone Number | 303-456-1500 |
News Archive
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
A study published today by the JAMA Network Open shows that in the period from October 2015 to September 2016 before the Affordable Care Act, a substantial portion of Medicare patients referred to home health care after hospitalization did not receive that care.
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
A study published today by the JAMA Network Open shows that in the period from October 2015 to September 2016 before the Affordable Care Act, a substantial portion of Medicare patients referred to home health care after hospitalization did not receive that care.
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7803 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.29 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.04 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 90.74 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.92 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.36 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 75.63 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.4 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 45.01 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.07 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.16 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 3.13 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 4.95 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.1 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 72.3 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 59.85 | 82.93 |
News Archive
Beyond vaccination, the broad-spectrum antiviral medication remdesivir has robust clinical evidence and is known as the best antiviral treatment to reduce severe COVID-19 infection in hospitalized patients. Research led by John F.X. Diffley of the Chromosome Replication Laboratory suggests a potential therapeutic target for treatment development is the viral RNA cap methyltransferases, essential for viral protein translation and immune evasion.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Timothy J. Yeatman, M.D., Moffitt's Associate Center Director for Clinical Investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota-based DNAPrintTM genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.
A study published today by the JAMA Network Open shows that in the period from October 2015 to September 2016 before the Affordable Care Act, a substantial portion of Medicare patients referred to home health care after hospitalization did not receive that care.
The Environmental Protection Agency has designated January as National Radon Action Month. According to recent reports from the World Health Organization, radon gas is responsible for approximately 20,000 deaths in the U.S. and 100,000 deaths worldwide each year.
› Verified 9 days ago
Arvada Care And Rehabilitation Center Location: 6121 W 60th Ave, Arvada, Colorado 80003 Phone: (303) 420-4550 | |